Advancements in Targeted Therapy for Rheumatoid Arthritis
DOI:
https://doi.org/10.61173/cztnnd21Keywords:
Targeted therapy, rheumatoid arthritis, clinical trialsAbstract
In recent years, the treatment of rheumatoid arthritis has broadened the variety. In particular, targeted therapy has become the most concerned treatment. Many of the shortcomings of traditional treatment modalities, such as expensive drugs and severe side effects, can be replaced by targeted therapy. Targeted therapy has not been widely used in clinical treatment, but it has been well understood and studied for many years. At the same time, many kinds of targeted drugs have been studied for the treatment of RA. This article analyzes the direction of several targeted therapy and drug research, about their different use methods, pathways, etc., and some are still under study. There are many research results, successful clinical trials, and significant improvement compared with traditional treatment. It can better treat patients and take care of their physical and mental health. Targeted therapy provides a reference for the subsequent research on the treatment of RA, and is also an excellent improvement of the treatment, but more clinical trials are still needed to truly populalize a variety of targeted therapy to patients.